Comarmond C, Jego P, Veyssier-Belot C, et al. Cessation of oral anticoagulants in antiphospholipid syndrome. Lupus 2017 Jan 1: 961203317699285. doi: 10.1177/0961203317699285.
2.
Ruiz-IrastorzaGCuadradoMJRuiz-ArruzaIet al.Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a task force at the 13th International Congress on antiphospholipid antibodies. Lupus2011; 20: 206–218.
3.
Criado-GarcíaJFernández-PueblaRLópez JiménezL. Anticoagulation treatment withdrawal in primary antiphospholipid syndrome when anticardiolipin antibodies become negative. Rev Clin Esp2008; 208: 135–135.
4.
Coloma BazánEDonate LópezCMoreno LozanoPCerveraREspinosaG. Discontinuation of anticoagulation or antiaggregation treatment may be safe in patients with primary antiphospholipid syndrome when antiphospholipid antibodies became persistently negative. Immunol Res2013; 56: 358–361.
